Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term th [Therapy]. Found 31 abstracts

no pagination
Levy MH, Back A, Bazargan S, Benedetti C, Billings JA, Block S, Bruera E, Carducci MA, Dy S, Eberle C, Foley KM, Harris JD, Knight SJ, Milch R, Rhiner M, Slatkin NE, Spiegel D, Sutton L, Urba S, Von Roenn JH, Weinstein SM, National Comprehensive Cancer N. Palliative care. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2006 Sep;4(8):776-818.
Manne SL, Andrykowski MA. Seeing the forest for the trees: a rebuttal.[comment]. Annals of Behavioral Medicine. 2006 Oct;32(2):111-4; discussion 115-8.
Manne SL, Andrykowski MA. Are psychological interventions effective and accepted by cancer patients? II. Using empirically supported therapy guidelines to decide.[see comment][comment]. Annals of Behavioral Medicine. 2006 Oct;32(2):98-103.
Murphy ME, Cassimeris L. A novel cancer therapy approach targeting microtubule function.[comment]. Cancer Biology & Therapy. 2006 Dec;5(12):1721-3.
Weaver C, Schiech L, Held-Warmkessel J, Kedziera P, Haney E, DiLullo G, Babb JS, Ruth K, Dell D, Barsevick A. Risk for unplanned hospital readmission of patients with cancer: results of a retrospective medical record review. Oncology Nursing Forum Online. 2006 May;33(3):E44-52.
Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, Montagnet C, Armstrong K. Survival associated with treatment vs observation of localized prostate cancer in elderly men.[see comment]. Jama. 2006 Dec 13;296(22):2683-93.
Dell DD. Spread the word about breast cancer. Nursing. 2005 Oct;35(10):56-63; quiz 63-4.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Anal canal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):510-5.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Colon cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):468-91.
Held-Warmkessel J. Managing three critical cancer complications. Nursing. 2005 Jan;35(1):58-63; quiz 63-4.
Henske EP. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatric Nephrology. 2005 Jul;20(7):854-7.
Knudson A. Retinoblastoma: teacher of cancer biology and medicine.[comment]. PLoS Medicine / Public Library of Science. 2005 Oct;2(10):e349.
Langer CJ. Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Clinical lung cancer. 2005 Jan;6(5):314-6, 2005 Mar.
Mu Z, Hachem P, Pollack A. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. The Prostate. 2005 Dec;65(4):331-40.
Ozols RF. Treatment goals in ovarian cancer. International Journal of Gynecological Cancer. 2005 May;15 Suppl 1:3-11.
Milling SW, Sai T, Silvers WK, Mintz B. Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells. Melanoma Research. 2004 Dec;14(6):555-62.
Sundermeyer ML, Goldstein LJ. American Society for Clinical Oncology 40th annual meeting, New Orleans, LA, 5-8 June 2004: breast cancer highlights. Breast Cancer Research. 2004 Jan;6(6):275-8.
Uzzo RG. Best therapies for prostate cancer. Bottom Line/Health. 2003 Feb;17(2):11-3.
Dell DD. Test your knowledge. Cachexia in patients with advanced cancer. Clinical Journal of Oncology Nursing. 2002 Jul;6(4):235-8.
Doll C. Falling through the cracks. Advance for Directors in Rehabilitation. 2002 Nov;11(11):[51].
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term th [Therapy]

th [Therapy] di [Diagnosis] Neoplasms pa [Pathology] et [Etiology] Female Male ge [Genetics] Neoplasm Staging Non-US Gov't Research Support Medical Oncology Aged mt [Methods] pp [Physiopathology] dt [Drug Therapy] Prognosis su [Surgery] Combined Modality Therapy Lung Neoplasms co [Complications] Prostatic Neoplasms Middle Aged Neoplastic Gene Expression Regulation sc [Secondary] Lymph Node Excision Patient Education rt [Radiotherapy] Antineoplastic Combined Chemotherapy Protocols Palliative Care Breast Neoplasms Mutation 0 (Antineoplastic Combined Chemotherapy Protocols) Cognitive Therapy st [Standards] Major Depressive Disorder me [Metabolism] im [Immunology] px [Psychology] sn [Statistics & Numerical Data] Risk Factors Risk Assessment Apoptosis 0 (Proto-Oncogene Proteins c-bcl-2) td [Trends] Bone Neoplasms Mass Screening Mastectomy Antisense) 0 (DNA Flow Cytometry Dendritic Cells Anus Neoplasms Cancer Patients bl [Blood] Colostomy 0 (Retinoblastoma Protein) Skin Neoplasms Adult mo [Mortality] Antisense DNA CD4-Positive T-Lymphocytes 0 (Stathmin) 0 (Peptide Fragments) 0 (Cytokines) 0 (Cyclin-Dependent Kinase Inhibitor p21) Disease Progression Cytotoxic T-Lymphocytes Retinoblastoma Small Interfering RNA 80 and over Aged Lymphedema Men Peptide Fragments Patient Readmission CD8-Positive T-Lymphocytes 0 (Melan-A protein) Clinical Trials Hematologic Tests ep [Epidemiology] Carcinoma ae [Adverse Effects] SEER Program Physician's Role Positron-Emission Tomography 0 (Imidazoles) Magnetic Resonance Imaging Salvage Therapy Pediatrics Proportional Hazards Models 118072-93-8 (zoledronic acid) Liver Neoplasms ai [Antagonists & Inhibitors] Skin Care Prostatectomy Pain Tuberous Sclerosis Proto-Oncogene Proteins c-bcl-2 Cyclin-Dependent Kinase Inhibitor p21 Inappropriate ADH Syndrome Secondary Hypertrophic Osteoarthropathy Stathmin 0 (Diphosphonates) Imidazoles 0 (Neoplasm Proteins) Treatment Outcome 0 (Immunoglobulin G) Cultured Cells Diphosphonates Experimental Melanoma Endpoint Determination Simian virus 40 Brain Neoplasms Colonic Neoplasms Radiotherapy Microtubules Immunoglobulin G Kidney Neoplasms Retrospective Studies Drug Hypersensitivity Monophenol Monooxygenase Immunologic Cytotoxicity Tests Medical Records United States Mammaplasty Patient Care Team pc [Prevention & Control] EC 3-4-22 (Caspases) Mammography Transfection Kaplan-Meiers Estimate EC 1-14-18-1 (Monophenol Monooxygenase) Observation Adjuvant Chemotherapy Cytokines EC 3-4-22 (caspase 7) Quality of Life Squamous Cell Carcinoma Tumor Suppressor Proteins Neoplasm Proteins Repressor Proteins Biopsy Leg Reference Values Neoplasm Invasiveness Tumor-Infiltrating Lymphocytes human) 0 (TP53 protein Disease-Free Survival Lymphatic Metastasis Prostate-Specific Antigen Signal Transduction 0 (Antineoplastic Agents)
Last updated on Thursday, April 02, 2020